| In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells M Puttini, AML Coluccia, F Boschelli, L Cleris, E Marchesi, ... Cancer research 66 (23), 11314-11322, 2006 | 468 | 2006 |
| Antibiotics Stimulate Formation of Vesicles in Staphylococcus aureus in both Phage-Dependent and -Independent Fashions and via Different Routes F Andreoni, M Toyofuku, C Menzi, R Kalawong, S Mairpady Shambat, ... Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 01439-18, 2019 | 112 | 2019 |
| Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients PK Buehler, AS Zinkernagel, DA Hofmaenner, PDW Garcia, CT Acevedo, ... Cell Reports Medicine 2 (4), 2021 | 96 | 2021 |
| Modulation of Staphylococcus aureus biofilm matrix by subinhibitory concentrations of clindamycin K Schilcher, F Andreoni, V Dengler Haunreiter, K Seidl, B Hasse, ... Antimicrobial agents and chemotherapy 60 (10), 5957-5967, 2016 | 94 | 2016 |
| DNase Sda1 Allows Invasive M1T1 Group A Streptococcus to Prevent TLR9-Dependent Recognition S Uchiyama, F Andreoni, RA Schuepbach, V Nizet, AS Zinkernagel PLoS pathogens 8 (6), e1002736, 2012 | 94 | 2012 |
| Clindamycin affects group A Streptococcus virulence factors and improves clinical outcome F Andreoni, C Zürcher, A Tarnutzer, K Schilcher, A Neff, N Keller, ... The Journal of infectious diseases 215 (2), 269-277, 2017 | 93 | 2017 |
| Increased Neutrophil Extracellular Trap–Mediated Staphylococcus aureus Clearance Through Inhibition of Nuclease Activity by Clindamycin and Immunoglobulin K Schilcher, F Andreoni, S Uchiyama, T Ogawa, RA Schuepbach, ... The Journal of infectious diseases 210 (3), 473-482, 2014 | 64 | 2014 |
| Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex R Piazza, V Magistroni, A Mogavero, F Andreoni, C Ambrogio, R Chiarle, ... Neoplasia 15 (5), 511-IN17, 2013 | 56 | 2013 |
| Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux U Matt, P Selchow, M Dal Molin, S Strommer, O Sharif, K Schilcher, ... International journal of antimicrobial agents 50 (1), 55-62, 2017 | 26 | 2017 |
| Streptococcal SpeB cleaved PAR-1 suppresses ERK phosphorylation and blunts thrombin-induced platelet aggregation M Ender, F Andreoni, AS Zinkernagel, RA Schuepbach PloS one 8 (11), e81298, 2013 | 22 | 2013 |
| Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib RG Piazza, V Magistroni, M Gasser, F Andreoni, A Galietta, L Scapozza, ... Leukemia 19 (1), 132-134, 2005 | 21 | 2005 |
| Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model A Tarnutzer, F Andreoni, N Keller, C Zürcher, A Norrby-Teglund, ... Clinical Microbiology and Infection 25 (4), 512. e7-512. e13, 2019 | 18 | 2019 |
| The IL-8 protease SpyCEP is detrimental for Group A Streptococcus host-cells interaction and biofilm formation F Andreoni, T Ogawa, M Ogawa, J Madon, S Uchiyama, RA Schuepbach, ... Frontiers in microbiology 5, 339, 2014 | 18 | 2014 |
| Human streptococcal necrotizing fasciitis histopathology mirrored in a murine model N Keller, F Andreoni, C Reiber, H Luethi-Schaller, RA Schuepbach, ... The American journal of pathology 188 (7), 1517-1523, 2018 | 17 | 2018 |
| Coiled-coil irregularities of the M1 protein structure promote M1–fibrinogen interaction and influence group A Streptococcus host cell interactions and virulence S Uchiyama, F Andreoni, C Zürcher, K Schilcher, M Ender, J Madon, ... Journal of Molecular Medicine 91, 861-869, 2013 | 17 | 2013 |
| Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis TR Veloso, A Zbinden, F Andreoni, M Giddey, J Vouillamoz, P Moreillon, ... International Journal of Medical Microbiology 303 (8), 498-504, 2013 | 16 | 2013 |
| Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients RG Piazza, V Magistroni, F Andreoni, A Franceschino, L Tornaghi, ... Leukemia 19 (11), 1985-1987, 2005 | 16 | 2005 |
| Overexpression of the single‐stranded DNA‐binding protein (SSB) stabilises CAG• CTG triplet repeats in an orientation dependent manner F Andreoni, E Darmon, WCK Poon, DRF Leach FEBS letters 584 (1), 153-158, 2010 | 10 | 2010 |
| The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with imatinib mesylate predicts for prolonged response … RG Piazza, V Magistroni, A Franceschino, F Andreoni, L Tornaghi, ... Blood Cells, Molecules, and Diseases 37 (2), 111-115, 2006 | 10 | 2006 |
| Immunoglobulin Attenuates Streptokinase-Mediated Virulence inStreptococcus dysgalactiae Subspeciesequisimilis Necrotizing Fasciitis F Andreoni, F Ugolini, N Keller, A Neff, V Nizet, A Hollands, ... The Journal of infectious diseases 217 (2), 270-279, 2018 | 8 | 2018 |
Annelies S. ZinkernagelUniversity Hospital Zurich, University of Zurich, SwitzerlandVerified email at usz.ch
